Twynsta Approval History 
- FDA approved: Yes (First approved October 16th, 2009)
- Brand name: Twynsta
- Generic name: telmisartan and amlodipine
- Company: Boehringer Ingelheim Pharmaceuticals Inc.
- Treatment for: High Blood Pressure
Twynsta (telmisartan/amlodipine) is an angiotensin II receptor blocker (ARB) and a dihydropyridine calcium channel blocker (DHP-CCB) combination product indicated for the treatment of hypertension alone or with other antihypertensive agents.
FDA Approval History for Twynsta
| Date | Article |
|---|---|
| Oct 19, 2009 |  FDA Approves Twynsta (telmisartan/amlodipine) for Hypertension |
See also...
Twynsta (telmisartan and amlodipine) Consumer Information
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
